The first placebo-controlled trial to verify the effectiveness and safety of deep brain stimulation (DBS) as a treatment for severe, treatment-resistant depression was reported by a team led by NARSAD Grantee Paul E....
- Mental Illnesses
- Finding Answers
- Recovery Stories
- NARSAD Grants & Prizes
- Apply for a NARSAD Grant
- Our Scientific Council
- NARSAD Young Investigator Grant
- NARSAD Independent Investigator Grants
- NARSAD Distinguished Investigator Grant
- Klerman & Freedman Prizes
- Outstanding Achievement Prizes
- Productive Lives Awards
- Productive Lives Nomination Form
- Frequently Asked Questions (FAQs)
- Get Involved
You are hereDiscoveries ›
Next Generation Therapies
In the most recent series of experiments with the potential to revolutionize the treatment of mood disorders, a team led by NARSAD Independent Investigator Grantee Carlos A. Zarate, Jr., M.D., successfully replicated a...
Watch Video Here
Deep Brain Stimulation (DBS) is a newer treatment option for patients with severe depression. Using pulses of current, DBS regulates specific areas of the brain (DBS is often referred to as the '...
NARSAD distinguished Investigator Grantee, Aaron T. Beck, the 'Father of Cognitive Behavioral Therapy (CBT)’ proved that it can be used to help treat the 'negative' symptoms of schizophrenia. CBT was invented by Beck in...
In 2010, Scientific Council Member Rene Hen, Ph.D., professor of pharmacology in the Departments of Psychiatry and Neuroscience at Columbia University, and a researcher at the New York State Psychiatric Institute, led a...